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Characteristic Magnetic Resonance Imaging Findings of the Neonatal Brain in RASopathies  
Abstract 
Background and Purpose: Neuroimaging features in newborns with RASopathies are rarely reported 
and to date there are no neuroimaging studies conducted in this population. Our aim was to investigate 
the occurrence of supratentorial and posterior fossa abnormalities on brain MRIs of newborns with a 
RASopathy. 
Material and Methods: An observational case-control study of newborns with a confirmed 
RASopathy was conducted. The presence of an intraventricular and/or parenchymal hemorrhage and 
punctate white matter lesions, and assessments of the splenium of the corpus callosum, gyrification of 
the cortical gray matter and enlargement of the extracerebral space were noted. The vermis height, 
transverse cerebellar diameter, cranial base angle, tentorial angle and infratentorial angle were 
measured.  
Results: We reviewed 48 brain MR studies performed at three academic centers in three countries 
between 2009 and 2017. Sixteen of these infants had a genetically confirmed RASopathy (Group 1) 
and 32 healthy infants were enrolled as the control group (Group 2). An increased rate of white matter 
lesions, extracerebral space enlargement, simplification of the cortical gyrification and white matter 
abnormalities were seen in Group 1 (p<0.001, for each). The vermis height of the patients was 
significantly lower, and tentorial and infratentorial angles were significantly higher in Group 1 
(p=0.01, p<0.001 and p=0.001; respectively).  
Conclusion: Newborns with a RASopathy had characteristic structural and acquired abnormalities in 
the cortical gray matter, white matter, corpus callosum, cerebellum and posterior fossa. This study 
provides novel neuroimaging findings on supratentorial and posterior fossa abnormalities in newborns 
with a RASopathy. 
Keywords: Brain; MRI; newborn; RASopathy  
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Introduction 
RASopathies are a family of multisystemic disorders with overlapping phenotypic features affecting 
approximately 1 in 1,000 newborns.1 These disorders are caused by germline mutations in genes 
coding for proteins which are part of the RAS/mitogen-activated protein kinase (MAPK) pathway, 
essential for cell proliferation, differentiation and senescence. There are over 15 genes identified so far 
in the RAS/MAPK signal pathway. Noonan syndrome (NS) is the most common RASopathy and 
Noonan-like syndrome (NLS), Costello syndrome (CS), cardio-facio-cutaneous (CFC) syndrome and 
NS with multiple lentigines (formerly known as LEOPARD syndrome) are other closely related 
disorders.2-4 Phenotypic features, associated risks and severity vary widely ranging from mild facial 
features to a lethal combination of congenital anomalies.
2
  
The prenatal manifestations of RASopathies are non-specific and include increased nuchal 
translucency/cystic hygroma, jugular cysts, hydrops fetalis, pleural/pericardial effusion and ascites, 
polyhydramnios, cardiac abnormalities typically dysplastic pulmonary valve and hypertrophic 
cardiomyopathy. Postnatally they present with craniofacial dysmorphism, respiratory distress, 
lymphatic dysplasia, cardiac defects, renal anomalies and hypotonia.
3,5
 Neuroimaging features in 
newborns and infants with RASopathies are rare since in most cases there is no indication for brain 
MRI. Intracranial abnormalities such as Chiari malformation, syringomyelia, cerebrovascular 
anomalies, benign external hydrocephalus, craniosynostosis and posterior fossa abnormalities have 
been reported in the pediatric and adult literature; however, to date no observational study was 
conducted to define the brain abnormalities in patients with a RASopathy.6-9 We conducted a case-
control study to determine the occurrence of supratentorial and posterior fossa abnormalities on brain 
MRIs in newborns with a RASopathy. 
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Patients and methods 
An observational case-control study of infants with a genetically confirmed RASopathy and severe 
clinical symptoms necessitating admission to the neonatal intensive care unit (NICU) at three 
academic centers (Wilhelmina Children’s Hospital, University Medical Center Utrecht, The 
Netherlands; The Hospital for Sick Children, University of Toronto, Canada and St. Michael’s 
Hospital, University of Bristol, United Kingdom) between 2009 and 2017 was conducted. The 
participating centers have a longstanding practice of incorporating brain MRI to the diagnostic process 
in severely ill newborns during their NICU course. For each infant with a RASopathy (Group 1), 2 
normal infants who were born with a gestational age of ±7 days were selected for the control group 
(Group 2). Demographic data were extracted from the patients’ files and/or hospital database. A 1:2 
case-control ratio was used to increase the statistical power of the analysis. In the Wilhelmina 
Children’s Hospital, until 2010, brain MRI was performed on a 1.5 Tesla Philips system (Intera or 
Achieva 1.5 T; Philips, Healthcare, Best, The Netherlands) and the protocol included sagittal T1-
weighted images (slice thickness: 5 mm) and axial T2-weighted images (slice thickness: 2-5 mm). 
Between 2010 and 2017 the brain MRI was done on a 3 Tesla Philips system (Achieva, Philips 
Medical Systems, Best, The Netherlands) and the recent protocol included conventional sagittal T1-
weighted images (slice thickness: 3 mm), axial 3D T1-weighted (slice thickness: 2 mm), and axial T2-
weighted imaging (slice thickness: 2 mm). The Hospital for Sick Children, Toronto followed a similar 
predefined brain MRI protocol according to their institutional guidelines during the study period and 
the MRI studies were all completed without pharmacological sedation on a Siemens 1.5 Tesla Avanto 
scanner with three-dimensional (3D) coronal volumetric T1-weighted and axial fast-spin echo T2-
weighted images performed at both time-points. University of Bristol followed a predefined MRI 
protocol according to their institutional guidelines and the MRI study was performed on a Siemens 3 
Tesla Magnetom Skyra scanner with three-dimensional (3D) coronal volumetric T1-weighted and 
axial T2-weighted images (slice thickness: 3 mm). Diffusion-weighted imaging (DWI) and 
susceptibility-weighted imaging (SWI) were obtained for distinguishing between ischemic and 
hemorrhagic lesions. DWI was acquired in the axial plane (slice thickness: 4 mm) and SWI was 
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obtained using a three-dimensional gradient-echo sequence with flow compensation. Only the high-
quality images suitable for scoring and measurements were included in the study.  
MRI findings and measurements 
MRI findings 
The presence of an intraventricular and/or cerebral parenchymal hemorrhage, cerebellar hemorrhage 
and punctate white matter lesions (PWML), visual assessment of the corpus callosum for hypoplasia 
and configuration of the splenium, gyrification of the cortex and enlargement of the extracerebral 
space were evaluated by consensus reads. 
MRI assessments 
The vermis height (VH) was measured from the culmen to the uvular lobule on the mid-sagittal image, 
with care to avoid including the cerebellar tonsil (Figure 1a). The transverse cerebellar diameter 
(TCD) was measured both on the coronal and axial views at the widest points of the cerebellum, 
traversing the dentate nuclei (Figure 1b and 1c). For the measurement of the cranial base angle (CBA) 
the fonticulus frontalis was used as the anterior landmark, mid-sella as the vertex point and the distal 
tip of the ossified clivus as the terminal point (Figure 1d). Measurement of the tentorial angle (TA) 
was by measuring the angle between Twining’s line and a line drawn through tentorium cerebelli. On 
every measurement, tuberculum sella was used as the originating point for TA (Figure 1e). 
Infratentorial angle (ITA) was measured as the angle between a line originating from the mid-sella 
drawn through the midpoint of the dural reflection of torcula herophili, to the inner cortex and the line 
drawn between the mid-sella and basion (Figure 1f).  
Two senior neuroradiologists (ML and SB) with more than 20 years’ experience in reading neonatal 
MRIs performed and supervised the measurements and assessed the images separately in a blinded 
fashion on digital picture archiving and communication (PACS) systems. To evaluate the 
interobserver agreement, 15 studies from 5 random patients were assessed and the interclass 
correlation coefficient (ICC) was calculated for each parameter. For the retrospective data analysis, the 
ethical committee of the University Medical Centre, Utrecht, waived informed consent owing to 
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analysis of anonymous clinical data. The same applied to the control subjects from Toronto. Written 
parental consent was obtained in Bristol and Toronto for patients. 
Statistical analysis 
Statistical analyses of the data were performed using the Statistical Package for the Social Sciences 
v21.0 program (SPSS Inc., Chicago, Ill., USA). All the continuous values were presented as mean ± 
standard deviation (SD). The categorical values were presented as number and percentage. Fisher’s 
exact test was used to compare categorical variables among groups. The Mann-Whitney U test was 
used to compare non-parametric variables and student t-test was used for the comparison of variables 
that showed normal distribution. Pearson's correlation coefficient was used to assess the correlation 
between the continuous variables. Spearman's correlation coefficient was used to search for the 
correlation between the non-normal variables. To evaluate the reliability of measurements across 
observers, ICC was calculated and classified as good for 0.8<ICC<0.9 and excellent for ICC>0.9. 
Statistical significance was set at p < 0.05. 
Results 
We reviewed 48 brain MR studies performed at thr e academic centers between 2009 and 2017. 
Sixteen of these infants had a genetic diagnosis of a RASopathy (Group 1) and 32 healthy infants were 
enrolled as the control group (Group 2). Eleven (68.7%) of the newborns in Group 1 were diagnosed 
with NS, while 5 (31.3%) had other RASopathies. Groups were similar in terms of gestational age 
(GA) and postmenstrual age (PMA) at the date of MR study (Table 1). Molecular genetic testing in all 
patients included the BRAF, HRAS, KRAS, MAP2K1, MAP2K2, PTPN11, RAF1, RIT1, SHOC2 and 
SOS1 genes. Eight out of 16 (50%) patients in Group 1 had a mutation in the PTPN11 gene (NS), 
while there were three (18.8%) with a mutation in HRAS (CS), one (6.2%) SHOC2 (NLS), one (6.2%) 
SOS1 (NS), one (6.2%) RAF1 (NS), one (6.2%) BRAF (CFC) and one (6.2%) RIT1 (NS). In one 
patient the PTPN11 mutation was paternally inherited, the father being diagnosed with NS with 
multiple lentigines. Data regarding white matter injury (WMI), intraventricular and cerebellar 
hemorrhages and their characteristics are given in Table 1. An increased rate of extra-cerebral space 
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enlargement, simplification of the cortical gyrification and white matter abnormalities were seen in 
Group 1 (Table 1 and Figure 2). There was a significant difference between the groups in terms of 
white matter lesions on conventional MRI, DWI and SWI (p<0.001) (Table 1). There was 1 (3.1%) 
infant in Group 2 who was found to have a Chiari type 1 malformation. When the infants in Group 1 
were categorized according to their mutation type [subgroup 1: PTPN11 mutation (+), subgroup 2: 
another type of mutation (+)] there were no differences between the subgroups in terms of WMI, IVH, 
cerebellar hemorrhage, extracerebral space enlargement or gyrification of the cerebral cortex (p>0.05 
for all parameters). 
Angle measures 
The agreement between the neuroradiologists evaluating the images showed an excellent correlation 
for the measurement of all angles (ICC=0.94, 0.96, 0.98 for TA, CBA, ITA; respectively). When the 
groups were compared with regards to the cerebellar measurements, the VH of the patients in Group 1 
was significantly lower than that of Group 2 (p=0.01) and VH showed a significantly positive 
correlation with GA in both groups (r=0.71; p<0.001). Although both axial and coronal TCDs of the 
cerebellum were reduced in Group 1, they were not significantly different across the groups (p=0.2 for 
both). Both cerebellar diameters showed a significantly positive correlation with GA in the study 
population (r=0.73, p<0.001 and r=0.74, p<0.001; respectively). Tentorial and infratentorial angles 
were found to be significantly higher in Group 1 (p<0.001 and p=0.001; respectively) (Table 1 and 
Figure 3) and TA showed a negative correlation with VH (r=-0.30, p=0.03). After controlling for GA 
and categorization according to the mutation type, there were no differences between subgroup 1 and 
subgroup 2 with regards to VH, TA, CBA and ITA (p>0.05 for all parameters). 
Outcome 
Ten (62.5%) patients in Group 1 died during infancy due to respiratory and cardiac complications and 
7 (70%) of these 10 infants died during their NICU stay due to multiple organ dysfunctions. Only one 
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of the surviving infants showed a normal developmental outcome. Characteristics of the patients with 
a RASopathy and data regarding their clinical features and outcome are given in Table 2. 
Discussion 
This is the first study that describes cranial MRI findings in newborn infants with a RASopathy. We 
have demonstrated that these infants had characteristic acquired and structural abnormalities in the 
posterior fossa including peripheral cerebellar hemorrhage, vermis hypoplasia and a steep tentorial 
configuration when compared with healthy controls. Moreover, these infants also showed an increased 
incidence of cerebral white matter lesions, enlarged extracerebral spaces, simplification of the cortical 
folding and structural corpus callosum abnormalities involving the splenium. Apart from anecdotal 
pediatric and adult case reports, data on global cerebral abnormalities in newborns with a RASopathy 
are rare in the literature. Brasil et al.10 reported cerebral abnormalities including isolated 
ventriculomegaly, posterior fossa anomalies and cerebral atrophy in infants with NS. Few studies 
included cerebral MRI and hypoplastic corpus callosum has only once been described in a patient with 
RASopathy with a mutation in the NF1 gene.11 A vertical position of the splenium of the corpus 
callosum has also been reported in the literature.
7
 We have seen that the splenium of the corpus 
callosum showed a visually abnormal vertical configuration in three of our infants and was 
underdeveloped in one. Furthermore, an enlarged extracerebral space, which was previously reported 
by Gripp et al.
7
 in one patient, and delayed gyrification of the cerebral cortex were present in the 
majority of our patients. To the best of our knowledge, these are all novel contributions.  
Total brain tissue grows linearly prenatally and Hüppi et al. demonstrated an almost three-fold 
increase in the global brain volume between 29 and 41 weeks postconception using volumetric MR 
measures.
12
 The inclination of the fetal tentorium gradually increases during pregnancy, as the rate of 
the cerebellar growth exceeds the rate of the occipital cerebral growth.13 However during the postnatal 
development, the tentorium moves inferiorly while progressively decreasing the TA.
14
 We found that 
the TA of the infants with a RASopathy was significantly higher than that of healthy controls at 
similar postmenstrual ages. An increased TA reflects the vertical configuration of the tentorium; 
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however, as we have seen a negative correlation between VH and TA, an increased TA in these 
patients can be explained by the effect of a genetic disorder causing disruption of developmental 
processes resulting in a permanent change in the morphology of the cranium with an effect on the 
growth of other structures, as defined previously.
9,15,16
    
Bony structures of the skull base also undergo changes, namely retroflexion of the basicranium in the 
intra-uterine and flexion in the postnatal period. This is reflected by an increase in the CBA during 
fetal development and a subsequent decrease in the postnatal period.
14,17
 Any anomaly during the 
orderly postero-anterior ossification of the cranial structures can interfere with normal formation of the 
bones and soft tissues, and may result in an abnormal configuration.18,19 The Ras/MAPK pathway 
plays a vital role in regulating components which are critical to normal development and it is not 
surprising that a dysregulation in this pathway has deleterious effects on both embryonic and later 
stages of development with implications on bony structures and cerebral tissues.1 It has been shown 
that patients with NS have various skull anomalies.
3,20
 Addissie et al.
21
 reported a 2-month-old female 
infant with NS who developed craniosynostosis and Ueda et al.9 reported a series of 9 infants with a 
RASopathy and craniosynostosis. It has also been shown that infants with CS had bone abnormalities 
resulting in macrocrania.
5
 In the present study we have demonstrated that CBA of the infants with 
RASopathy were markedly depressed, which reflects the abnormal skeletal development of the 
basicranium. Furthermore, a significantly increased ITA also confirms the deviant cranial cavity floor 
extending posteriorly, as shown in our study. Although the detailed pathophysiologic mechanism 
remains unknown, we speculate that rather than the acquired lesions such as hemorrhages, these bone 
abnormalities and consequently changed angulations may result in the anomalous formation of the 
posterior fossa, which in turn change the tentorial configuration.       
In recent decades, cumulative evidence has shown that cerebellar function extends beyond 
sensorimotor control to relate cerebellum with higher-order functions such as attention, language, 
executive function and cognition.22,23 Preterm infants with cerebellar hemorrhage can develop 
cognitive impairment and the vermis is considered especially important for cognitive outcome.24 
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Consistent with the literature we have seen that cerebellar vermis had an increase in size, as reflected 
by the increased VH, with increasing gestational age. Interestingly, we have found that newborns with 
a RASopathy had a small vermis when compared with controls. Although the cerebellum of the infants 
in our study showed a trend towards a decreased diameter on coronal and axial planes, this was not 
statistically significant when compared to healthy controls. We might speculate that the disrupting 
effect of these genetic conditions was more prominent on the central part of the organ, which contains 
more neural networks than the peripheral parts. Hemorrhages were seen in the peripheral parts of the 
cerebellum. It is unlikely that these hemorrhages contributed to the hypoplasia of the vermis in these 
infants, as the hemorrhages were of recent onset and the hypoplasia was already present at birth. 
Further investigation is needed to find if the hemorrhagic cerebellar lesions and the small vermis, as 
seen in our patients, can be used in the future as an imaging finding to better predict outcome; 
however, we would recommend a brain MRI in an infant with a suspected diagnosis of a RASopathy, 
particularly when the neonatal course is complicated. 
The present study has several limitations. First, due to the retrospective design of the study it is 
difficult to make causal inferences. Second, owing to the rarity of the severe neonatal presentation that 
requires NICU admission, the number of patients included in the study was relatively small. Finally, 
since the majority of the patients were diagnosed with NS, these results might not be generalizable for 
all RASopathies; however, NS is the most common type of these closely related disorders in the 
literature, hence it is expected to see the same distribution in our cohort. Moreover, we have observed 
the same characteristic findings consistently in every patient in our study regardless of their final 
genetic diagnosis.  
It is of interest that, despite a wide range of neurodevelopmental outcomes in children with a 
RASopathy, no brain MRI studies have been performed previously to explore whether this could be 
explained by differences in brain structure and development. Our data may suggest that an early MRI 
could help to better prognosticate outcome. The infants included in our study were at the severe end of 
the spectrum, as they required admission to a NICU. Thus, further studies are needed on those with a 
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less complicated neonatal course. During the neonatal period, RASopathies can be challenging to 
diagnose as characteristic morphologic findings may not be fully established and recognition of these 
neuroimaging findings should facilitate the diagnosis of these conditions.5 Our study provides novel 
neuroimaging information that could help neonatologists, neuroradiologists and geneticists to suspect 
the diagnosis and be aware of the possible complications during their follow-up. Further studies are 
warranted to define the exact pattern of injury and malformation in these infants, and correlate their 
neuroimaging findings with their neurodevelopmental outcome. 
Conclusion 
This study provides novel neuroimaging findings on supratentorial and posterior fossa abnormalities in 
newborns with a RASopathy. These structural and acquired changes in the neonatal brain might 
prompt the physician to consider the diagnosis of a RASopathy and we suggest that a cranial MRI be 
considered for these patients, especially when the neonatal course is complicated.  
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Table 1: Clinical characteristics and MRI angle measurements and assessments. 
 
 
Group 1 
(n=16) 
Group 2 
(n=32) 
p* 
 
Gestational age (weeks) 
 
35.6±4.2 
 
37.3±4.5 
 
0.1
a 
Postmenstrual age at MRI (weeks) 37.6±4.8 39.8±6.5 0.2a 
Vermis height (mm.) 20.5±4.4 23.7±3.9 0.01
a
 
Transcerebellar diameter 
   Axial 
   Coronal 
 
48.6±9.1 
48.8±9.6 
 
52.3±9.8 
52.7±9.7 
 
0.2
a 
0.2
a
 
Cranial base angle (degree) 130.3±4.0 134.8±5.3 0.005
b 
Tentorial angle (degree) 55.4±3.4 46.6±5.8 <0.001b 
Infratentorial angle (degree) 52.2±6.5 47.7±4.0 0.001
a
 
Intraventricular hemorrhage (n, %) 8 (47) 0 (0) <0.001c 
Cerebellar abnormality (n, %) 
   Hemorrhagic lesion 
   Hemorrhagic-Cystic lesion 
9 (56) 
  6 (67) 
  3 (33) 
0 (0) 
 
 
<0.001
c 
 
 
Enlarged extra-cerebral space (n, %) 
   Mild 
   Severe 
13 (81) 
  10 (77) 
  3 (23) 
0 (0) <0.001c 
Delayed cortical gyrification (n, %) 12 (75) 0 (0) <0.001c 
WMI after cerebral hemorrhage  
(n, %) 
   Punctate white matter lesion 
   Cystic lesion 
Abnormality in DWI, n=12 (n, %) 
   Focal restriction 
   Extensive restriction 
 
9 (56) 
  7 (78) 
  2 (22) 
7 (58) 
  6 (86) 
  1 (14) 
 
0 (0) 
 
 
  - 
 
 
<0.001
c 
 
 
 
 
Corpus callosum abnormality (n, %) 
   Vertical appearance 
   Hypoplasia 
4 (25) 
  3 (75) 
  1 (25) 
0 (0) <0.001c 
a
Mann-Whitney U test, 
b
t-test, 
c
Fisher’s exact test 
*Adjusted for gestational age where appropriate 
DWI: diffusion-weighted imaging; IVH: intraventricular hemorrhage; MRI: magnetic resonance 
imaging; WMI: white-matter injury. 
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Table 2: Characteristics of the patients with a RASopathy, their clinical features and outcome. 
 
Case G.A Disorder 
Genetic 
Mutation 
Antenatal Findings Respiratory System Cardiac Findings 
 
Other Postnatal Findings 
 
Outcome 
 
1 
 
373/7 
 
NS 
 
PTPN11 
Hydrops fetalis,  
pleural effusion 
Severe respiratory distress 
 
HCM 
 
Chylothorax   Died in the neonatal period 
 
2 
 
285/7 NLS SHOC2 Polyhydramnios Severe respiratory distress 
 
HCM 
 
Necrotizing enterocolitis Died in the neonatal period 
 
3 
 
340/7 NS RAF1 
Polyhydramnios, 
pyelectasis,  
talipes equinovarus 
Severe respiratory distress HCM - 
 
Died at 1.5 months 
 
 
4 
 
342/7 NS SOS1 
Polyhydramnios,  
cystic hygroma, 
pyelectasis 
Mild respiratory distress  
 
HCM 
 
- 
Developed West Syndrome, 
severe cognitive delay,  
visual impairment and 
cerebral palsy 
 
5 
 
290/7 NS PTPN11 Polyhydramnios Severe respiratory distress - Chylothorax 
 
Died in the neonatal period  
 
 
6 
 
403/7 NS PTPN11 - 
 
Severe respiratory distress 
 
ASD Multiple skeletal dysplasias Severe cognitive delay 
7 383/7 NS PTPN11 
- 
 
Severe respiratory distress 
HCM, 
Valvular pulmonary 
stenosis 
Chylothorax 
 
Severe cognitive delay 
 
8 404/7 NS PTPN11 - Mild respiratory distress HCM JMML Died at 6 months 
9 320/7 NS PTPN11 - Severe respiratory distress 
HCM,  
PPHN 
HIE 
Osteofibrous dysplasia of the 
lower extremities,  
failure to thrive,  
ND within normal range 
10 402/7 CFCS BRAF - - ASD Congenital CMV infection 
Generalized developmental 
delay, visual impairment 
11 362/7 NS RIT1 
 
Hydrops fetalis, 
pleural effusion, 
 
Severe respiratory distress SVT 
HIE, 
chylothorax, 
chronic renal failure 
Died at 3.5 months 
12 340/7 CS HRAS - Severe respiratory distress 
HCM, VSD,  
chaotic atrial ectopia, 
tachycardia 
Multiple cardiac arrests Died at 8.5 months 
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13 392/7 NS PTPN11 - - HCM, ASD Myeloproliferative disorder 
ADHD, severe autism 
spectrum disorder 
14 366/7 CS HRAS 
Polyhydramnios, 
adrenal hemorrhage, 
skeletal dysplasia 
Meconium aspiration 
syndrome 
PPHN, SVT, 
severe hypotension 
HIE, multiple skeletal 
dysplasias 
Died at 6 months 
15 386/7 NS PTPN11 - Severe respiratory distress 
HCM,  
complete AVSD 
Chylothorax Died in the neonatal period 
16 286/7 CS HRAS - Severe respiratory distress 
HCM, arrhythmia, 
hypotension  
Chylothorax, chylascites,  
small bowel volvulus 
Died in the neonatal period 
 
ADHD; attention deficit hyperactivity disorder; ASD: atrial septal defect; AVSD: atrioventricular septal defect; CFCS: Cardio-facio-cutaneous syndrome; CS: Costello syndrome;  F: female; G.A: gestational age; 
HCM: hypertrophic cardiomyopathy; HIE: hypoxic ischemic encephalopathy; JMML: juvenile myelomonocytic leukaemia; M: male; NS: Noonan Syndrome; NLS: Noonan syndrome-like disorder with loose anagen 
hair; PPHN; persistent pulmonary hypertension of the newborn; SVT: supraventricular tachycardia; VSD; ventricular septal defect;  
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Figure 1: Measurement techniques used in the study. a) Preterm infant, gestational age 35 weeks 6 days. 
T1-weighted MR sequence shows measurement of the vermis height from the culmen to the uvular lobule on 
the mid-sagittal image; b and c) Preterm infant, gestational age 30 weeks 6 days. T2-weighted MR images 
show cerebellar diameter measurement at the widest points of the cerebellum on axial and coronal images, 
respectively; d) Preterm infant, gestational age 33 weeks 4 days. T1-weighted image shows cranial base 
angle measurement with the fonticulus frontalis used as the anterior landmark, mid-sella as the vertex point 
and the distal tip of the ossified clivus as the terminal point; e) Measurement of the tentorial angle between 
Twining’s line and a line drawn through tentorium cerebelli with tuberculum sella used as the originating 
point; f) T1-weighted MR sequence shows measurement of the infratentorial angle using a line originating 
from the mid-sella drawn through the midpoint of the dural reflection of torcula herophili, to the inner cortex 
and the line drawn between mid-sella and basion.  
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Figure 2: Characteristic MRI findings of the infants with a RASopathy. a) Preterm infant, gestational age 28 
weeks 6 days, MRI performed at postmenstrual age 30 weeks 5 days. T2-weighted midsagittal MR image 
shows a prominently vertical tentorium and splenium of the corpus callosum; b) Preterm infant, gestational 
age 34 weeks 2 days. T2-weighted axial MR image demonstrates the presence of hemorrhagic and cystic 
lesions in the peripheral regions of the cerebellum; c) Preterm infant, gestational age 34 weeks 2 days. T2-
weighted axial MRI shows mildly enlarged extracerebral space together with severe white matter injury, 
which evolved into extensive cysts; d) Preterm infant, gestational age 34 weeks. Axial T2-weighted MR 
sequence shows severely enlarged extracerebral space, punctate white matter lesions and a small amount of 
blood in the lateral ventricles.  
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Figure 3: Box-plot graphs show the comparison of the vermis height (top-left), cranial base angle (top-
right), tentorial angle (bottom-left) and infratentorial angle (bottom-right) between infants with a 
RASopathy and the control group.  
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